US Stock MarketDetailed Quotes
MURA Mural Oncology
- 3.280
- +0.130+4.13%
Close Aug 16 16:00 ET
55.88MMarket Cap-320P/E (TTM)
3.280High3.150Low45.08KVolume3.150Open3.150Pre Close144.84KTurnover0.33%Turnover RatioLossP/E (Static)17.04MShares57.20052wk High0.27P/B45.22MFloat Cap2.88052wk Low--Dividend TTM13.79MShs Float57.200Historical High--Div YieldTTM4.13%Amplitude2.880Historical Low3.212Avg Price1Lot Size
Mural Oncology Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -27.47%34.28M | -22.93%34.03M | 6.12%196.24M | 23.54%58.51M | -6.06%46.31M | 47.26M | 44.16M | 5.45%184.92M | 47.36M | 49.3M |
| Selling and administrative expenses | 42.32%6.73M | 91.27%7.17M | 73.17%30.71M | 227.43%16.27M | 31.57%5.96M | --4.73M | --3.75M | 14.05%17.73M | --4.97M | --4.53M |
| -General and administrative expense | 42.32%6.73M | 91.27%7.17M | 73.17%30.71M | 227.43%16.27M | 31.57%5.96M | --4.73M | --3.75M | 14.05%17.73M | --4.97M | --4.53M |
| Research and development costs | -35.23%27.54M | -33.51%26.87M | -0.99%165.53M | -0.36%42.24M | -9.87%40.35M | --42.53M | --40.41M | 4.61%167.19M | --42.39M | --44.77M |
| Operating profit | 27.47%-34.28M | 22.93%-34.03M | -6.12%-196.24M | -23.54%-58.51M | 6.06%-46.31M | -47.26M | -44.16M | -5.45%-184.92M | -47.36M | -49.3M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 2.71M | 3.12M | 951K | |||||||
| Other non- operating income (expenses) | --2.71M | --3.12M | --951K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 33.21%-31.56M | 29.98%-30.92M | -5.60%-195.29M | -21.53%-57.56M | 6.06%-46.31M | -47.26M | -44.16M | -5.45%-184.92M | -47.36M | -49.3M |
| Income tax | 0 | 0 | 148.98%12.16M | 61.89%1.98M | 270.32%4.97M | 2.91M | 2.31M | 7,082.35%4.88M | 1.22M | 1.34M |
| Net income | 37.08%-31.56M | 33.46%-30.92M | -9.29%-207.45M | -22.55%-59.54M | -1.25%-51.28M | -50.16M | -46.47M | -8.19%-189.81M | -48.58M | -50.64M |
| Net income continuous Operations | 37.08%-31.56M | 33.46%-30.92M | -9.29%-207.45M | -22.55%-59.54M | -1.25%-51.28M | ---50.16M | ---46.47M | -8.19%-189.81M | ---48.58M | ---50.64M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 37.08%-31.56M | 33.46%-30.92M | -9.29%-207.45M | -22.55%-59.54M | -1.25%-51.28M | -50.16M | -46.47M | -8.19%-189.81M | -48.58M | -50.64M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 37.08%-31.56M | 33.46%-30.92M | -9.29%-207.45M | -22.55%-59.54M | -1.25%-51.28M | -50.16M | -46.47M | -8.19%-189.81M | -48.58M | -50.64M |
| Basic earnings per share | 38.12%-1.86 | 33.92%-1.84 | -9.29%-12.43 | -22.54%-3.5672 | -1.25%-3.0728 | -3.006 | -2.7844 | -8.19%-11.3738 | -2.9112 | -3.0347 |
| Diluted earnings per share | 38.12%-1.86 | 33.92%-1.84 | -9.29%-12.43 | -22.54%-3.5672 | -1.25%-3.0728 | -3.006 | -2.7844 | -8.19%-11.3738 | -2.9112 | -3.0347 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg